Agents Used in Antiretroviral Therapy

  • Authors: Philip Grant, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 4/9/19 (What's New)

Summary

  • Viral DNA may either lie latent or be transcribed into mRNA
  • Cells containing transcriptionally latent viral DNA are not susceptible to antiretroviral therapy, providing an important mechanism for persistence of infection during antiretroviral therapy
  • Transcription and translation of viral genome results in variety of proteins needed for mature HIV to replicate and infect other cells

Action required

Keywords: Initial Antiretroviral Therapy, Special Populations, Treatment Complications

©2018 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.